Key Highlights
- PATH shares have climbed 25.5% from July 31, ending Friday’s session at $16.01
- First quarter FY2027 revenue increased 17% year-over-year to reach $418 million
- Company achieved GAAP operating income of $28 million, marking its inaugural profitable quarter
- Current price sits 20.8% higher than the $13.25 analyst consensus target
- Second quarter forecast indicates sequential revenue decrease of 4.9% to $397.5 million midpoint
Shares of UiPath (PATH) finished Friday’s trading at $16.01, marking a weekly gain of 6.4% and a 25.5% increase since the end of July. The automation software company’s stock price now exceeds price targets set by several major Wall Street firms, including UBS, BMO Capital, DA Davidson, and Bank of America.
The sharp upward movement followed the company’s Q1 FY2027 earnings release, which demonstrated tangible financial improvement. Top-line revenue grew 17% compared to the prior-year period, reaching $418 million. The company’s annual recurring revenue increased 12% to $1.901 billion. Most notably, UiPath achieved GAAP operating income of $28 million, representing its first quarter in the black under generally accepted accounting principles.
The company added $49 million in net new ARR during the quarter, a significant improvement over the $27 million recorded in the comparable period a year earlier.
Chief Executive Daniel Dines highlighted that the company’s “agentic products are moving from pilot to production,” signaling an emphasis on artificial intelligence-powered automation as a central element of future expansion.
Analysts Remain Unconvinced
The recent price surge hasn’t translated into upgraded recommendations from Wall Street analysts. The consensus rating across 16 analysts tracked remains at Neutral, with an average price target of $13.25. Based on Friday’s closing price, this suggests a potential decline of approximately 17%.
UBS maintains a Hold rating alongside a $12 price objective. BMO Capital and DA Davidson similarly rate PATH as Hold with targets ranging from $12 to $13. Bank of America has assigned a Sell rating with a $13 price target.
PATH currently trades 34.5% higher than its 50-day moving average and 25.7% above its 200-day moving average. The stock’s 52-week peak stands at $19.84, meaning Friday’s close remains roughly 19% below that level.
Thursday saw the stock’s most significant single-session gain, jumping 9.3% to reach $16.68 before retreating modestly on Friday. Trading volume on Friday totaled approximately 52.1 million shares, falling short of the 64.4 million three-month average.
Near-Term Outlook Shows Sequential Decline
UiPath provided Q2 FY2027 revenue guidance in the range of $395 million to $400 million. The $397.5 million midpoint represents a 4.9% quarter-over-quarter decline, though it reflects 9.8% growth versus Q2 of the previous fiscal year.
The company expects non-GAAP operating income of $75 million for Q2, representing a decrease from Q1’s $92 million.
Management projects ARR will reach $1.932 billion by the conclusion of Q2, implying sequential growth of 1.6%.
UiPath’s strong gross margin profile provides flexibility to continue investing in AI innovation and go-to-market activities without requiring additional borrowing.
Customer attrition among smaller accounts presents a potential headwind. The majority of customer departures are occurring in this segment, creating uncertainty around the sustainability of net new ARR growth going forward.
Chief Accounting Officer Hitesh Ramani divested 50,000 PATH shares across Thursday and Friday, generating approximately $831,250 in proceeds. These sales were executed pursuant to a Rule 10b5-1 trading plan established in March, indicating they were predetermined rather than discretionary decisions. Ramani retains direct ownership of 235,052 shares.
The company is slated to release its next quarterly earnings report on September 3 following the market close.





